Perrigo Co Plc - Net Worth and Insider Trading

Perrigo Co Plc Net Worth

The estimated net worth of Perrigo Co Plc is at least $161,397 dollars as of 2024-11-13. Perrigo Co Plc is the 10% Owner of Proteostasis Therapeutics Inc and owns about 145,403 shares of Proteostasis Therapeutics Inc (PTI) stock worth over $161,397. Details can be seen in Perrigo Co Plc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Perrigo Co Plc has not made any transactions after 2016-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Perrigo Co Plc

Perrigo Co Plc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Perrigo Co Plc owns 4 companies in total, including Proteostasis Therapeutics Inc (PTI) , Prothena Corp PLC (PRTA) , and Yumanity Therapeutics Inc (YMTX) among others .

Click here to see the complete history of Perrigo Co Plc’s form 4 insider trades.

Insider Ownership Summary of Perrigo Co Plc

Ticker	Comapny	Transaction Date	Type of Owner
PTI	Proteostasis Therapeutics Inc	2016-02-17	10 percent owner
PRTA	Prothena Corp PLC	2013-12-18	10 percent owner
YMTX	Yumanity Therapeutics Inc	2016-02-10	10 percent owner
		2016-02-10	10 percent owner

Perrigo Co Plc Latest Holdings Summary

Perrigo Co Plc currently owns a total of 1 stock. Perrigo Co Plc owns 145,403 shares of Proteostasis Therapeutics Inc (PTI) as of February 17, 2016, with a value of $161,397.

Latest Holdings of Perrigo Co Plc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PTI	Proteostasis Therapeutics Inc	2016-02-17	145,403	1.11	161,397

Holding Weightings of Perrigo Co Plc

Perrigo Co Plc Form 4 Trading Tracker

According to the SEC Form 4 filings, Perrigo Co Plc has made a total of 0 transactions in Proteostasis Therapeutics Inc (PTI) over the past 5 years. The most-recent trade in Proteostasis Therapeutics Inc is the acquisition of 6,250 shares on February 17, 2016, which cost Perrigo Co Plc around $1,000,000.

Insider Trading History of Perrigo Co Plc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Perrigo Co Plc Trading Performance

GuruFocus tracks the stock performance after each of Perrigo Co Plc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Perrigo Co Plc is 115.48%. GuruFocus also compares Perrigo Co Plc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Perrigo Co Plc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Perrigo Co Plc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Perrigo Co Plc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	71.13
Relative Return to S&P 500(%)	65.23

Perrigo Co Plc Ownership Network

Ownership Network List of Perrigo Co Plc

No Data

Ownership Network Relation of Perrigo Co Plc

Perrigo Co Plc Owned Company Details

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Perrigo Co Plc is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Prothena Corp PLC do?

Who are the key executives at Prothena Corp PLC?

Perrigo Co Plc is the 10 percent owner of Prothena Corp PLC. Other key executives at Prothena Corp PLC include See Remarks Karin L Walker , Chief Operating Officer Brandon S. Smith , and Chief Regulatory Officer Carol D. Karp .

Prothena Corp PLC (PRTA) Insider Trades Summary

Over the past 18 months, Perrigo Co Plc made no insider transaction in Prothena Corp PLC (PRTA). Other recent insider transactions involving Prothena Corp PLC (PRTA) include a net sale of 45,000 shares made by Karin L Walker , a net sale of 40,000 shares made by Carol D. Karp , and a net sale of 25,000 shares made by Michael J Malecek .

In summary, during the past 3 months, insiders sold 0 shares of Prothena Corp PLC (PRTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 321,333 shares of Prothena Corp PLC (PRTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 321,333 shares.

Prothena Corp PLC (PRTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prothena Corp PLC Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Perrigo Co Plc is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Perrigo Co Plc is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Perrigo Co Plc made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 10,000 shares made by Keith Baker .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 50,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

Perrigo Co Plc Mailing Address

Above is the net worth, insider trading, and ownership report for Perrigo Co Plc. You might contact Perrigo Co Plc via mailing address: 515 Eastern Avenue, Allegan Mi 49010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.